# OnCo record nct03315364 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03315364/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03315364", "NCT03315364" ;
  schema:name "Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy"@en ;
  schema:alternateName "OPTIMAL"@en ;
  schema:description "A phase 2/3 trial of Oral paclitaxel in advanced solid tumours, run by Daehwa Pharmaceutical Co., Ltd., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct03315364/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03315364> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2/3" ;
  schema:startDate "2017-12-18" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/daehwa-pharmaceutical/> .